Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Inter-Arm Differences in Continuous Glucose Monitor Readings in Adults With Diabetes

1. november 2026 oppdatert av: Sachin Shah, University of the Pacific

Evaluation of Inter-Arm Differences in Continuous Glucose Monitor Glucose Readings in Patients With Type 1 and Type 2 Diabetes

This is a clinical trial looking at differences in continuous glucose monitor (CGM) glucose readings between the left and right arms in adults with type 1 or type 2 diabetes. The study will enroll 60 participants who will wear a CGM sensor on both arms for 14 days.

Studieoversikt

Detaljert beskrivelse

This study is a prospective, non-randomized clinical trial designed to evaluate differences in continuous glucose monitor (CGM) glucose readings between the left and right arms in adults with type 1 or type 2 diabetes.

The study will enroll 60 participants. Each participant will wear two FreeStyle Libre 3 Plus CGM sensors simultaneously for 14 days, with one sensor placed on each arm.

The primary objective is to compare the frequency of hypoglycemic events, defined as glucose readings below 70 mg/dL, between the left and right arms. Secondary analyses will evaluate differences in Level 1 and Level 2 hypoglycemia and time below range. Additional analyses will compare time in range, time above range, time below range, and average glucose between the two arms.

CGM data from the two sensors will be collected and compared to evaluate differences in glucose readings between the left and right arms.

Studietype

Intervensjonell

Registrering (Antatt)

60

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiekontakt

  • Navn: Innovative Clinical and Outcomes Research (iCOR)
  • Telefonnummer: 925-255-5374
  • E-post: icor@pacific.edu

Studiesteder

    • California
      • Stockton, California, Forente stater, 95211
        • University of the Pacific
        • Ta kontakt med:
          • Innovative Clinical and Outcomes Research (iCOR)
          • Telefonnummer: 9252555374
          • E-post: icor@pacific.edu
        • Hovedetterforsker:
          • Sachin A Shah, PharmD
        • Underetterforsker:
          • Allen Shek, PharmD
        • Underetterforsker:
          • Aydin Shek

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

18 år og eldre (Voksen, Eldre voksen)

Tar imot friske frivillige

Nei

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion Criteria:

  • Adults 18 years of age and over
  • Diagnosed with type 1 or 2 diabetes mellitus
  • Female participants with childbearing potential must have a negative urine pregnancy stick test, which has been confirmed by investigators
  • Willingness to wear a CGM on each arm for 2 weeks
  • A1c <7% within the past 6 months
  • Willing to attend 3 virtual call meetings over the course of the trial
  • Have active health insurance throughout the duration of the study
  • Willing to refrain from consuming or using commercial products containing ascorbic acid (vitamin C) or salicylic acid, and certain skincare products for the duration of the study due to their known potential to interfere with CGM readings (exposure via food is allowed)
  • Participants must have a mobile phone that is connected to the internet and compatible with both "FreeStyle Libre 3" and "Libre by Abbott" apps

Exclusion Criteria:

  • Under the age of 18
  • Any active dermatologic condition on the upper arms
  • Implanted medical devices (e.g., pacemaker, insulin pump)
  • Use of any medical or other devices (e.g., TMS) incompatible with the FreeStyle Libre 3 Plus CGM
  • Critically ill or dialysis patients
  • Planned high-frequency electrical heat treatment (diathermy) during the study period
  • Currently taking hydroxyurea
  • History of or planned gastric bypass within the study period
  • Current systemic infections
  • Subjects who are unable to fully understand the study or consent process will not be included in the study due to the lack of a qualified medical translator
  • Refusal to sign the informed consent document or HIPAA authorization form
  • Pregnant, planned pregnancy during study period, or currently breastfeeding
  • History of allergic reactions or hypersensitivity to adhesives
  • Blood transfusion within the previous 3 months

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Annen
  • Tildeling: N/A
  • Intervensjonsmodell: Enkeltgruppeoppdrag
  • Masking: Ingen (Open Label)

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: Left and Right Arm CGM Wear

Participants will wear two FreeStyle Libre 3 Plus continuous glucose monitors (CGMs) simultaneously for 14 days, with one sensor applied to the back of the upper arm on each arm. Participants will continue their normal daily routine during the study period. CGM data from the left and right arms will be compared.

Two FreeStyle Libre 3 Plus continuous glucose monitors (CGMs) will be worn simultaneously for 14 days. One sensor will be applied subcutaneously to the back of the upper arm on each arm. The sensors measure glucose in the interstitial fluid, and data from the left and right arms will be collected and compared.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Difference in Frequency of Hypoglycemic Events Between Left and Right Arms
Tidsramme: 14 days

Difference in the frequency of hypoglycemic events (<70 mg/dL) between the left arm and right arm.

14 days

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Difference in Frequency of Level 1 Hypoglycemic Events Between Left and Right Arms
Tidsramme: 14 days

Difference in the frequency of Level 1 hypoglycemic events (54 to <70 mg/dL) between the left arm and right arm.

14 days
Difference in Frequency of Level 2 Hypoglycemic Events Between Left and Right Arms
Tidsramme: 14 days

Difference in the frequency of Level 2 hypoglycemic events (<54 mg/dL) between the left arm and right arm.

14 days
Difference in Percentage of Time Below Range (<70 mg/dL) Between Left and Right Arms
Tidsramme: 14 days

Difference in percentage of time below range (TBR) <70 mg/dL between the left and right arms.

14 days
Difference in Percentage of Time Below Range (54 to <70 mg/dL) Between Left and Right Arms
Tidsramme: 14 days

Difference in percentage of time below range (TBR) from 54 to <70 mg/dL (Level 1 hypoglycemia) between the left and right arms.

14 days
Difference in Percentage of Time Below Range (<54 mg/dL) Between Left and Right Arms
Tidsramme: 14 days

Difference in percentage of time below range (TBR) <54 mg/dL (Level 2 hypoglycemia) between the left and right arms.

14 days

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Antatt)

4. november 2026

Primær fullføring (Antatt)

4. november 2027

Studiet fullført (Antatt)

4. november 2027

Datoer for studieregistrering

Først innsendt

1. november 2026

Først innsendt som oppfylte QC-kriteriene

1. november 2026

Først lagt ut (Faktiske)

5. november 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

5. november 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

1. november 2026

Sist bekreftet

1. november 2026

Mer informasjon

Begreper knyttet til denne studien

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

NEI

IPD-planbeskrivelse

Individual participant data will not be shared with others.

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Ja

produkt produsert i og eksportert fra USA

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere